Clinical Trial Update: BIO 300 Oral Powder Safety and Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and pharmacokinetics of BIO 300 oral powder in Acute Radiation Syndrome is completed, with results posted on 2024-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Syndrome

Drugs mentioned

• BIO 300

Snippet

Sponsor: Humanetics Corporation | Conditions: Acute Radiation Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2024-05-03